Repligen Corp (RGEN) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $176.93 -1%
EPS Growth %: 0.0%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: 0.0%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Repligen Corp (NASDAQ: RGEN) reported Q2 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $8.63 million versus the consensus estimate of $7.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Express Q3 earnings preview: stronger print expected on resilient spending
- Balchem Corp. (BCPC) Tops Q3 EPS by 14c
- Rogers Communications (RCI) Tops Q3 EPS by 42c
Create E-mail Alert Related Categories
Earnings, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
